Viewing Study NCT01755767


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-02-18 @ 10:42 AM
Study NCT ID: NCT01755767
Status: COMPLETED
Last Update Posted: 2021-04-06
First Post: 2012-12-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy
Sponsor: Daiichi Sankyo
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ARQ197-A-U303
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View